Evan N. Cohen

4.9k total citations
62 papers, 2.0k citations indexed

About

Evan N. Cohen is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Evan N. Cohen has authored 62 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Oncology, 18 papers in Cancer Research and 15 papers in Molecular Biology. Recurrent topics in Evan N. Cohen's work include Cancer Cells and Metastasis (27 papers), Cancer Genomics and Diagnostics (10 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Evan N. Cohen is often cited by papers focused on Cancer Cells and Metastasis (27 papers), Cancer Genomics and Diagnostics (10 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Evan N. Cohen collaborates with scholars based in United States, Slovakia and Italy. Evan N. Cohen's co-authors include James M. Reuben, Hui Gao, Massimo Cristofanilli, Antonio Giordano, Naoto T. Ueno, Michal Mego, Sanda Tin, Wendy A. Woodward, Simone Anfossi and Gabriel N. Hortobágyi and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Evan N. Cohen

61 papers receiving 2.0k citations

Peers

Evan N. Cohen
Christophe Lebœuf France
Lalit R. Patel United States
Thomas Zwingers Germany
Eliza Wiercinska Germany
Bin Shi China
Gerwin Heller Austria
Tushar D. Bhagat United States
Puthiyaveettil N. Raghunath United States
Marco Lo Iacono Italy
Christophe Lebœuf France
Evan N. Cohen
Citations per year, relative to Evan N. Cohen Evan N. Cohen (= 1×) peers Christophe Lebœuf

Countries citing papers authored by Evan N. Cohen

Since Specialization
Citations

This map shows the geographic impact of Evan N. Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evan N. Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evan N. Cohen more than expected).

Fields of papers citing papers by Evan N. Cohen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evan N. Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evan N. Cohen. The network helps show where Evan N. Cohen may publish in the future.

Co-authorship network of co-authors of Evan N. Cohen

This figure shows the co-authorship network connecting the top 25 collaborators of Evan N. Cohen. A scholar is included among the top collaborators of Evan N. Cohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evan N. Cohen. Evan N. Cohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iwase, Toshiaki, Wenli Dong, Daniel L. Adams, et al.. (2024). Circulating cancer-associated macrophage-like cells and macrophage-related cytokines in obese patients with advanced breast cancer who undergo neoadjuvant chemotherapy. Journal of Cancer. 15(18). 5855–5862. 1 indexed citations
2.
Cohen, Evan N., Gitanjali Jayachandran, Hui Gao, et al.. (2023). Phenotypic Plasticity in Circulating Tumor Cells Is Associated with Poor Response to Therapy in Metastatic Breast Cancer Patients. Cancers. 15(5). 1616–1616. 10 indexed citations
3.
Miller, Michael Craig, et al.. (2023). Analytical performance of the FDA-cleared Parsortix® PC1 system. PubMed. 12. 26–33. 17 indexed citations
4.
Qiu, Lianqun, Pei Lin, Mahsa Khanlari, et al.. (2023). The Clinicopathologic Features and Molecular Signatures of Blastoid High-Grade B Cell Lymphoma, Not Otherwise Specified. Modern Pathology. 36(12). 100349–100349. 2 indexed citations
5.
Lin, Steven H., Evan N. Cohen, Ziyi Li, et al.. (2023). 732 Immune activation with plinabulin enhances anti-tumor response combining radiation with immune checkpoint blockade. SHILAP Revista de lepidopterología. A826–A826. 1 indexed citations
6.
Cohen, Evan N., et al.. (2020). Antigen-agnostic microfluidics-based circulating tumor cell enrichment and downstream molecular characterization. PLoS ONE. 15(10). e0241123–e0241123. 17 indexed citations
7.
Cohen, Evan N., Tamer M. Fouad, Bang‐Ning Lee, et al.. (2019). Elevated serum levels of sialyl Lewis X (sLeX) and inflammatory mediators in patients with breast cancer. Breast Cancer Research and Treatment. 176(3). 545–556. 23 indexed citations
8.
Cohen, Evan N., et al.. (2018). Systematic review of definitions for success in pelvic organ prolapse surgery. International Urogynecology Journal. 29(11). 1697–1704. 22 indexed citations
9.
Harano, Kenichi, Takahiro Kogawa, Jimin Wu, et al.. (2017). Thrombocytosis as a prognostic factor in inflammatory breast cancer. Breast Cancer Research and Treatment. 166(3). 819–832. 19 indexed citations
10.
Wang, Xin Shelley, Qiuling Shi, Loretta A. Williams, et al.. (2014). Longitudinal analysis of patient-reported symptoms post-autologous stem cell transplant and their relationship to inflammation in patients with multiple myeloma. Leukemia & lymphoma. 56(5). 1335–1341. 27 indexed citations
11.
Giordano, Antonio, Hui Gao, Evan N. Cohen, et al.. (2013). Clinical relevance of cancer stem cells in bone marrow of early breast cancer patients. Annals of Oncology. 24(10). 2515–2521. 27 indexed citations
12.
13.
Giordano, Antonio, Hui Gao, Simone Anfossi, et al.. (2012). Epithelial–Mesenchymal Transition and Stem Cell Markers in Patients with HER2-Positive Metastatic Breast Cancer. Molecular Cancer Therapeutics. 11(11). 2526–2534. 172 indexed citations
14.
Debeb, Bisrat G., Evan N. Cohen, Li Li, et al.. (2012). Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells. Breast Cancer Research and Treatment. 134(2). 495–510. 53 indexed citations
15.
Cohen, Evan N., et al.. (2011). Proceedings of IATL. 1 indexed citations
16.
Reuben, James M., Hui Gao, Evan N. Cohen, et al.. (2011). Primary breast cancer patients with high risk clinicopathologic features have high percentages of bone marrow epithelial cells with ALDH activity and CD44+CD24lo cancer stem cell phenotype. European Journal of Cancer. 47(10). 1527–1536. 71 indexed citations
17.
Debeb, Bisrat G., Xiaomei Zhang, Savitri Krishnamurthy, et al.. (2010). Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells. Molecular Cancer. 9(1). 180–180. 62 indexed citations
18.
Krishnamurthy, Savitri, Massimo Cristofanilli, Balraj Singh, et al.. (2010). Detection of minimal residual disease in blood and bone marrow in early stage breast cancer. Cancer. 116(14). 3330–3337. 97 indexed citations
19.
Jain, Nitin, James M. Reuben, Hagop M. Kantarjian, et al.. (2009). Synthetic tumor‐specific breakpoint peptide vaccine in patients with chronic myeloid leukemia and minimal residual disease. Cancer. 115(17). 3924–3934. 40 indexed citations
20.
Ferrajoli, Alessandra, Bang-Ning Lee, Ellen Schlette, et al.. (2008). Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia. Blood. 111(11). 5291–5297. 304 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christophe Lebœuf Breakdown of academic impact, for papers by Lalit R. Patel Breakdown of academic impact, for papers by Thomas Zwingers Breakdown of academic impact, for papers by Eliza Wiercinska Breakdown of academic impact, for papers by Bin Shi Breakdown of academic impact, for papers by Gerwin Heller Breakdown of academic impact, for papers by Tushar D. Bhagat Breakdown of academic impact, for papers by Puthiyaveettil N. Raghunath Breakdown of academic impact, for papers by Marco Lo Iacono
Rankless by CCL
2026